Research Paper Volume 16, Issue 2 pp 1021—1048

Potential prognosis and immunotherapy predictor TFAP2A in pan-cancer

class="figure-viewer-img"

Figure 5. GSEA of differential genes in high and low TFAP2A expression group. Enrichment pathways in ACC, BRCA, CHOL, COAD, DLBC, ESCA, GBM, HNSC, LUAD, LUSC, OV, PAAD, SKCM, THCA, UCEC, UVM. The blue curve represents “REACTOME_GPCR_ LIGAND_BINDING” pathway, the red curve represents “REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_ LYMPHOID_AND_A_NON_LYMPHOID_CELL” pathway.